MedsFacts Meta-Analysis covering adverse side effect reports of AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) patients who developed DEHYDRATION.

Introduction: MedsFacts provides MD-approved analysis to help both patients and physicians accurately research and assess the risk-reward trade off for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration, social media, and MedsFacts user submissions. Between January 2004 and October 2012, 1 individuals taking AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) reported DEHYDRATION to the FDA. A total of 1 AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

Topics covered: This page is designed to help you determine the relationship, if any, between AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) and DEHYDRATION. In doing so, we compare AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) with other drugs that cause DEHYDRATION, to help you evaluate whether or not AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) causes DEHYDRATION. Likewise, this page shows the most highly-reported side effects of AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE), so you can see if DEHYDRATION ranks among AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE)'s most well-known side effects.

The Dashboard explained: The Dashboard first shows general Summary Statistics for AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) and DEHYDRATION, such as the raw number and percentage of patients in FDA reports who used AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) and developed DEHYDRATION. Next, the Dashboard lists the most common reasons (indications) why AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) was prescribed for patients. We then display a pie-chart which shows, in aggregate, what we believe represents general physician opinion of the safety of AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE). This pie-chart summarizes, for all FDA reports covering AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE), whether or not the treating physician felt AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) (versus other drugs the patient was taking) was responsible for the adverse side-effects. After the pie-chart, we itemize the most common side effects in FDA studies covering AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE). You may click on any of these side effects to learn more about them, in general, or specifically for AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE). Finally, we identify the drugs most widely associated with AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) in FDA literature. You may also click on any of these drugs to view it's dashboard.

Dashboard view of our research literature concerning AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) :

Summary Statistics
Reports of any side effect of AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) : 1
Percentage of AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) patients where DEHYDRATION is a reported side effect: 100%

FDA reports of any drug causing DEHYDRATION : 51306
Average percentage for all medicated patients where DEHYDRATION is reported as a complication: 0.32155572150264%
Most frequent diagnoses/indications for prescribing AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE):
( 0 patients )
Physician opinion on AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) as adverse event culprit:

(* global)
Twitter feed for AMARYL (GLIMEPIRINE) (GLIMEPRIRIDE) - Pending/Beta

Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.

Copyright 2013 MedsFacts
Privacy Policy
Terms of use